Plane crash in Kenya kills at least 6 after charity's medical jet smashes into neighbourhood and erupts in fireball
Click to share on Facebook (Opens in new window)
SIX people have died after a medical light aircraft crashed into a residential area in Kenya.
The tragic incident saw buildings destroyed in the vicinity of the impact.
Sign up for Scottish Sun
newsletter
Sign up
3
Rescuers gather near debris at the scene
Credit: Reuters
3
People react near the scene
Credit: Reuters
3
A helicopter flies by as emergency personnel work at the scene
Credit: Reuters
The plane took of from Nairobi's Wilson airport on Thursday afternoon.
Local police commander Anthony Keter told The Standard newspaper the horror incident happened near Morendat Farm on the northeastern side of Lake Naivasha.
"We are now looking for bodies in the wreckage.
"So far we have recovered four bodies," a Red Cross worker at the scene said.
The plane reportedly crashed into a building before bursting into flames, according to reports.
"We have lost four people, including the pilot... it was all fatal," said Kiambu County commissioner Henry Wafula.
"The house that it landed on... two people again also died," he said, and two people on the ground were "seriously injured".
Pictures from the scene showed rescuers rushing to the scene of the tragedy.
"The plane started burning while in the air," resident Tasha Wanjira said.
Another resident, Irene Wangui, said the "plane passed by our building shaking it".
Amref Flying Doctors CEO Stephen Gitau said one of their plaes had been "involved in a fatal accident today".
They did not provide any further details.
Nairobi based Amref was founded in 1957 as the Flying Doctors of East Africa.
The cause of the crash remains unknown.
More to follow... For the latest news on this story, keep checking back at The U.S. Sun, your go-to destination for the best celebrity news, sports news, real-life stories, jaw-dropping pictures, and must-see videos.
Like us on Facebook at TheSunUS and follow us on X at @TheUSSun
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Scottish Sun
4 hours ago
- Scottish Sun
University puts up ‘bonkers' posters warning its students not to eat conkers
Read on to find out why bosses put up the posters in the international student study CONKED OUT University puts up 'bonkers' posters warning its students not to eat conkers Click to share on X/Twitter (Opens in new window) Click to share on Facebook (Opens in new window) A UNIVERSITY launched a 'bonkers' campaign warning its students not to eat conkers. East Anglia University has put up posters showing a conker in a red circle with a cross through it. Sign up for Scottish Sun newsletter Sign up Above the image is written, 'Do not eat conkers!' and below, 'These are not chestnuts and eating them will make you unwell'. Bosses put up the posters in the international student study centre fearing a new intake of Chinese students might think they are edible. Around 1,000 of the 17,000 students at the Norwich university hail from China. It is feared some new arrivals could confuse conkers — known as horse chestnuts — with water chestnuts, which are prized in China for their crunchy texture and mild sweetness. Horse chestnuts, however, contain a toxin called aesculin which can cause abdominal pain, nausea and vomiting. A source said: 'The uni looks out for student welfare and thought this was an area they may need guidance on.' The university said: 'As far as we're aware, no students have attempted to eat conkers and we'd like to keep it that way. 'The posters were prompted by a member of staff who previously worked with Chinese students and recalled similar confusion elsewhere. 'It's part of our broader commitment to student wellbeing.' 1 East Anglia University has put up posters warning its students not to eat conkers
Scottish Sun
4 hours ago
- Scottish Sun
New drug dubbed ‘Viagra for women' which ‘improves sexual response and sexual function' is set to be launched
The firm behind the drug expects sales to top £7.5billion a year BEDTIME BOOST New drug dubbed 'Viagra for women' which 'improves sexual response and sexual function' is set to be launched Click to share on X/Twitter (Opens in new window) Click to share on Facebook (Opens in new window) A DRUG dubbed 'Viagra for women' is set to be launched. Inventor Dr Iona Weir said Myregyna has been proven in trials to 'improve sexual response and sexual function' in women over 50. Sign up for Scottish Sun newsletter Sign up 2 A drug that has been dubbed 'Viagra for women' is set to be launched Credit: Getty The New Zealand-based cell biologist added: 'It actually boosts natural hydration, 'Men got Viagra, but women got nothing, right? "This is going to be the first non-hormonal treatment that will give you your sex life back.' Her firm, Weir Science, expects sales of the plant-based drug to top £7.5billion a year. It aims to reverse the effects of Genitourinary Syndrome of Menopause (GSM) in millions of post-menopausal women worldwide. The doctor claims Myregyna, which is plant based, has produced spectacular results in a clinical trial of New Zealand women over the age of 55. She claims there were women in the trial who hadn't had sex for years - and after using the drug were now having regular sex and orgasms without pain. But she added it's not just about sex. 'It will enable you to go to a disco, whatever you want to do, and jump, you know, go to the gym, basically, enjoy life again' she told a New Zealand magazine. Dr Weir is currently in talks with two global drug firms and is in the process of registering the product with the Food and Drug Administration in the US. This Morning viewers furious as couple have sex on 'female viagra' in racy TV experiment
Scottish Sun
7 hours ago
- Scottish Sun
‘Out of the box' pill could eliminate life-threatening allergic reactions for millions of people
Plus, everything you need to know about anaphylaxis below GAME-CHANGER 'Out of the box' pill could eliminate life-threatening allergic reactions for millions of people Click to share on X/Twitter (Opens in new window) Click to share on Facebook (Opens in new window) POTENTIALLY deadly food allergies could be prevented by an asthma drug. The breakthrough could lead to new protection for millions, say scientists. Sign up for Scottish Sun newsletter Sign up 2 Zileuton, which was used in the study, is available on prescription in the UK Credit: Getty Zileuton, an oral pill used to treat asthma, worked "shockingly well" in blocking allergic reactions to food in mice in new research. Researchers found the mice went from being 95 per cent susceptible to anaphylaxis to 95 per cent protected. Now a clinical trial has been launched to test the same approach in humans. Zileuton, recently approved in the United States and available on prescription in the UK, was found to "nearly eliminate" life-threatening allergic reactions to food allergens in mice. The discovery came after scientists identified, in mice, a previously unknown role for a gene called DPEP1, which they found is "essential" in regulating anaphylaxis - a rapid and potentially deadly allergic reaction. By using it to block the pathway involving this gene, the team at at Northwestern University in Illinois nearly eliminated allergic responses in mice that were previously highly susceptible to food-induced anaphylaxis. The mice were given peanut extract orally shortly after receiving Zileuton while the team monitored for symptoms. Study co-senior author Dr. Stephanie Eisenbarth, of Northwestern University Feinberg School of Medicine, said: "It was actually shocking how well Zileuton worked." The discovery of the new pathway came after a years-long forward genetic screen, a process where researchers breed generations of mice to narrow down the specific genes responsible for biological differences, such as susceptibility to food allergy. Once the team found the DPEP1 gene controlled leukotrienes in the gut - inflammatory molecules already targeted by asthma drugs - they tested Zileuton, which blocks their production. Allergist explains the difference between allergies and anaphylaxis Food allergies are on the rise, affecting around one in 10 people. But scientists say predicting an allergic person's risk of anaphylaxis and preventing severe reactions from accidental exposure remains a challenge. Currently, there are only two approved treatments for certain food allergies - and no cure. One is an oral immunotherapy for peanut allergy, which doesn't work for all patients and can itself trigger anaphylaxis. The other, omalizumab, is an expensive jab that also isn't effective for all allergy patients. But the research team say Zileuton is a simple pill that temporarily shields allergy patients by blocking the body's anaphylactic pathway before it activates. 2 Researchers are now looking to trial the drug in humans Credit: Getty Prof Williams said: "This is a totally different, out-of-the-box approach to treat food allergy, unlike anything we've tried before. "We've seen tragic, even fatal reactions from hidden ingredients like ground peanuts in a sauce. "For parents sending their child to a birthday party, or for anyone flying where they can't control what's being served, this could be a powerful protective drug." The Northwestern team launched a small clinical trial in July to test whether blocking the newly identified pathway with Zileuton in humans is as effective as it was in mice. Their findings, published in the journal Science, also shed light on the long-standing puzzle of why some people test positive for food allergens but experience no symptoms when they eat the food. Dr Eisenbarth said: "Let's say you're told you're allergic to peanuts based on a blood test, but you've eaten peanuts your whole life without any problems. "This pathway we discovered may be one explanation for why some of those people are protected." She says that group has been a "challenge" for doctors and a source of stress for patients because current diagnostic tests only estimate allergy risk, not tolerance. Dr Eisenbarth said: "Our findings open a whole new area for future research into how people develop food allergies in the first place, and why some react while others don't." She added: "If you'd asked me five or six years ago to guess the pathway that would lead to this discovery, I never would have picked this gene or the leukotriene molecules."
